Assessment of sedative activity of fraxin: In vivo approach along with receptor binding affinity and molecular interaction with GABAergic system
Drug Development Research · 2024
DOI: 10.1002/ddr.22250 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, 2024. Verfasst von Sonaly Akter Mukty und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Bangladesh. Hauptthemen laut MEDLINE: Hypnotics and Sedatives, Molecular Docking Simulation, Diazepam, Sleep. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: Researcher Supporting Project.
Abstract (Originalsprache)
Insomnia is a sleep disorder in which you have trouble falling and/or staying asleep. This research aims to evaluate the sedative effects of fraxin (FX) on sleeping mice induced by thiopental sodium (TS). In addition, a molecular docking study was conducted to investigate the molecular processes underlying these effects. The study used adult male Swiss albino mice and administered FX (10 and 20 mg/kg, i.p.) and diazepam (DZP) (2 mg/kg) either separately or in combination within the different groups to examine their modulatory effects. After a period of 30 min, the mice that had been treated were administered (TS: 20 mg/kg, i.p.) to induce sleep. The onset of sleep for the mice and the length of their sleep were manually recorded. Additionally, a computational analysis was conducted to predict the role of gamma‐aminobutyric acid (GABA) receptors in the sleep process and evaluate their pharmacokinetics and toxicity. The outcomes indicated that FX extended the length of sleep and reduced the time it took to fall asleep. When the combined treatment of FX and DZP showed synergistic sedative action. Also, FX had a binding affinity of −7.2 kcal/mol, while DZP showed −8.4 kcal/mol. The pharmacokinetic investigation of FX demonstrated favorable drug‐likeness and strong pharmacokinetic characteristics. Ultimately, FX demonstrated a strong sedative impact in the mouse model, likely via interacting with the GABA A receptor pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Bangladesh.
- Bioinformatics and Drug Innovation Laboratory, BioLuster Research Center Ltd., Gopalganj, Dhaka, Bangladesh.
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
- Department of Drug Science and Technology, University of Turin, Turin, Italy.
- Pharmacy Discipline, Khulna University, Khulna, Bangladesh.
ORCID-Profile: Md Shimul Bhuia, Siddique Akber Ansari, Muhammad Torequl Islam
Förderung
- Researcher Supporting Project
Zitieren
APA
Mukty, S. A., Hasan, R., Bhuia, M. S., Saha, A. K., Rahman, U. S., Khatun, M. M., Bithi, S. A., Ansari, S. A., Ansari, I. A., & Islam, M. T. (2024). Assessment of sedative activity of fraxin: In vivo approach along with receptor binding affinity and molecular interaction with GABAergic system. Drug Development Research. https://doi.org/10.1002/ddr.22250
Vancouver
Mukty SA, Hasan R, Bhuia MS, Saha AK, Rahman US, Khatun MM, et al. Assessment of sedative activity of fraxin: In vivo approach along with receptor binding affinity and molecular interaction with GABAergic system. Drug Development Research. 2024. doi:10.1002/ddr.22250
BibTeX
@article{Mukty2024,
author = {Mukty, Sonaly Akter and Hasan, Rubel and Bhuia, Md Shimul and Saha, Anik Kumar and Rahman, Umme Sadea and Khatun, Mst Muslima and Bithi, Sumaya Akter and Ansari, Siddique Akber and Ansari, Irfan Aamer and Islam, Muhammad Torequl},
title = {Assessment of sedative activity of fraxin: In vivo approach along with receptor binding affinity and molecular interaction with GABAergic system},
journal = {Drug Development Research},
year = {2024},
doi = {10.1002/ddr.22250}
}
EUVIMED